Trial Condition(s):

Computed Tomography

Study to test the usability of a new injector to administer contrast media into humans for diagnostic purposes (PERCENT)

Bayer Identifier:

20521

ClinicalTrials.gov Identifier:

NCT03875469

EudraCT Number:

Not Available

Study Completed

Trial Purpose

This study investigates if a new medical device, which injects contrast media and flushing solution into humans to increase the visibility of images taken of the human body for diagnostic purposes, is easier to handle, quicker and cheaper than an older injector.

Inclusion Criteria
- Adult subjects referred for contrast-enhanced computer tomography using a power injector
Exclusion Criteria
- Pregnant and lactating women
                - Subjects with know hypersensitivity to iodinated contrast media
                - Subjects with unacceptable renal function per local guidelines

Trial Summary

Enrollment Goal
425
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
BPI1000045
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Medscan

Merrylands, Australia, 2160

Status
Completed
 
Locations

Maastricht University Medical Center

Maastricht, Netherlands, 6229

Status
Completed
 

Trial Design